Effect of home exercise on patients with implantable cardioverter defibrillators
Clinical Effectiveness of Exercise After an Implantable Cardioverter Defibrillator (ICD)
This study is testing a home exercise program for people with an implantable cardioverter defibrillator (ICD) to see if it helps them get more active safely, and it’s looking for participants from the Seattle area to join in for 12 weeks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10941357 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of a home-based exercise program designed for individuals with an implantable cardioverter defibrillator (ICD). The program, called Exercise-ICD (E-ICD), aims to help patients safely initiate and monitor their exercise routines after receiving an ICD. Participants will be randomly assigned to either the E-ICD program or usual care, with the goal of measuring changes in physical activity levels over a 12-week period. The study will involve 210 patients across three sites in the greater Seattle area, utilizing a mixed-methods approach to assess both effectiveness and implementation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have received an implantable cardioverter defibrillator and are looking to improve their physical activity levels.
Not a fit: Patients who are unable to participate in physical activity due to severe mobility limitations or other contraindications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance physical activity levels and overall health outcomes for patients with ICDs.
How similar studies have performed: Previous studies have shown promising results with similar home-based exercise interventions for cardiac patients, indicating potential for success in this approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Dougherty, Cynthia M — University of Washington
- Study coordinator: Dougherty, Cynthia M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.